ea0077mte2 | Bone and Calcium | SFEBES2021
Peel Nicola
In common with other chronic conditions, persistence with treatment for osteoporosis is poor, with fewer than 50% of patients continuing treatment by 12 months. Reasons for this are multifactorial; treatment does not lead to symptomatic benefit, may be difficult to take and can cause adverse effects. Furthermore, poor compliance may not be overt and may be unintentional. Monitoring an individuals response to treatment can identify those with subopt...